Stephan Eder

CEO, Pharmanovia

United Kingdom

About

Pharmanovia’s purpose is to improve patients’ lives globally. We do this by providing patients access to trusted established medicines across the globe as well as bringing to market innovative medicines to address unmet medical need. We have a diverse team delivering high-quality solutions, ethically and sustainably across our four core therapeutic areas – Endocrinology, Neurology, Cardiovascular and Oncology. I am convinced that what we do truly matters, that we have a tremendous positive impact on people’s lives every day.

Experience

  • Chief Executive Officer at Pharmanovia
    Oct 2025 - Present · 10 mos

  • STADA Group (Full-time · 5 yrs 5 mos)
    • EVP Western Europe & Germany
      Jun 2023 - Oct 2025 · 2 yrs 5 mos

    • EVP Europe & Germany
      Apr 2022 - Jun 2023 · 1 yr 3 mos

    • EVP Russia/CIS
      Jun 2020 - Apr 2022 · 1 yr 11 mos

  • Employee at Sandoz/Hexal
    Feb 2020 - May 2020 · 4 mos

  • Sandoz (10 yrs 9 mos)
    • CEO Hexal AG and Country Head Germany
      May 2017 - Feb 2020 · 2 yrs 10 mos

    • Country Head UK & Ireland
      Dec 2013 - Apr 2017 · 3 yrs 5 mos

    • Head Business Unit OTC
      Sep 2010 - Dec 2013 · 3 yrs 4 mos

  • Director Corporate Strategy at Novartis International AG
    Aug 2007 - May 2009 · 1 yr 10 mos